An indemnity bond, effectively, offers legal protection to a manufacturer in case a vaccine causes adverse events. A frontline worker receives her first dose of the COVID-19 vaccine. | Photo Credit: PTI
Key Highlights
Pfizer was one of the first manufacturers to apply for emergency-use authorisation (EUA) for its vaccine in India, but was forced to withdraw its application following the central government s insistence that it conduct bridging trials in the country
In response to an RTI application, the central government stated that there was no proposal being considered to indemnify or exempt vaccine manufacturers from liability borne out adverse events caused via inoculation